Compatibility and stability of valsartan in a solid pharmaceutical formulation
Valsartan (VAL) is a highly selective blocker of the angiotensin II receptor that has been widely used in the treatment of hypertension. Active pharmaceutical ingredient compatibility with excipients (crospovidone, hypromellose, magnesium stearate, microcrystalline cellulose and titanium dioxide) is...
Saved in:
Main Authors: | Tamíris Amanda Júlio (Author), Igor Fernando Zâmara (Author), Jerusa Simone Garcia (Author), Marcello Garcia Trevisan (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2013-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thermal Compatibility of New ACEI Derivatives with Popular Excipients Used to Produce Solid Pharmaceutical Formulations
by: Mateusz Broncel, et al.
Published: (2024) -
LC-MS characterization of valsartan degradation products and comparison with LC-PDA
by: Sumaia Araújo Pires, et al.
Published: (2015) -
Solid State Stability and Kinetics of Degradation for Candesartan-Pure Compound and Pharmaceutical Formulation
by: Valentina Buda, et al.
Published: (2020) -
Influence Mechanism of Drug-Polymer Compatibility on Humidity Stability of Crystalline Solid Dispersion
by: Chunhui Hu, et al.
Published: (2023) -
Stability and Compatibility Studies of Levothyroxine Sodium in Solid Binary Systems-Instrumental Screening
by: Ionuț Ledeți, et al.
Published: (2020)